Copyright
©The Author(s) 2025.
World J Hepatol. Jul 27, 2025; 17(7): 107668
Published online Jul 27, 2025. doi: 10.4254/wjh.v17.i7.107668
Published online Jul 27, 2025. doi: 10.4254/wjh.v17.i7.107668
Table 1 Different biomarkers for metabolic dysfunction-associated steatotic liver disease assessment
Index/biomarker | Abbreviation | Formula | Ref. |
Body mass index | BMI | Weight (kg)/height² (m²) | Ma et al[83] |
Dallas steatosis index | DSI | McHenry et al[84], McHenry et al[85] | |
Fatty liver index | FLI | [e0953 × ln (TG) + 0.139 × BMI + 0.718 × ln (GGT) + 0.053 × WC - 15.745]/[1 + e0953 × ln (TG) + 0.139 × BMI + 0.718 × ln (GGT) + 0.053 × WC - 15.745) × 100] | Bedogni et al[76] |
Fibroblast growth 21 | FGF-21 | Molecular kits | Gallego-Durán et al[86], Keskin et al[87] |
Framingham steatosis index | FSI | -7.981 + 0.011 × age - (0.146 × sex, female = 1, male = 0) + 0.173 × BMI + 0.007 × TG + (0.593 × hypertension, yes = 1, no = 0) + (0.789 × diabetes, yes = 1, no = 0) + (1.1 × ALT/AST ratio ≥ 1.33, yes = 1, no = 0) | Long et al[88] |
Hepatic steatosis index | HSI | 8 × ALT/AST ratio + BMI (+ 2, if diabetes mellitus; + 2, if woman) | Lee et al[77], Chung et al[89] |
Homeostatic model assessment | HOMA | Fasting glucose × fasting insulin/405 | Matthews et al[90] |
Leukocyte cell-derived chemotaxin 2 | LECT2 | Molecular kits | Suzuki et al[91] |
Lipid accumulation product | LAP | WC and fasting plasma TG: LAP = (WC – 65) × TG for men, and LAP = (WC – 58) × TG for women | Ebrahimi et al[92], Li et al[93] |
Micro RNA | MiR-122-5p, miR-151a-3p, miR-126-5p and miR-21-5p | Molecular kits | Tobaruela-Resola et al[75] |
N3 MASH for MASLD | N3-MASH | N3-MASH = 5.278 × log10(CK-18) + 4.423 × log10(CXCL10) + 1.833 × BMI – 21.652 | Zhang et al[94] |
N7 MASH for MASLD | N7-MASH | N7-MASH = 3.639 × log10(CK-18) + 4.811 × log10(CXCL10) + 2.911 × log10(squalene epoxidase) + 0.050 × ALT + 0.869 × glycated hemoglobin – 0.117 × AST + 1.193 × BMI – 33.023 | Zhang et al[94] |
Triglyceride-glucose index | TyG | Ln (TG × glucose/2) | Simental-Mendía et al[95], Zou et al[96] |
TyG-BMI | TyG-BMI | BMI × TyG index | Khamseh et al[81], Zou et al[96] |
TyG-HDL cholesterol | TyG-HDL-c | TyG/HDL cholesterol | |
TyG-WC | TyG-WC | TyG index × WC | Khamseh et al[81] |
TyG-waist-to-height ratio | TyG-WHtr | TyG index × WC/height | Zhang et al[82] |
TyG-weight-adjusted-waist index | TyG-WWI | TyG index × WC/weight | Zhang et al[82] |
Uric acid | UA | Plasma/urine concentrations | Chang et al[97], Fukuda et al[98] |
Uric acid to creatinine ratio | UACR | UA/creatinine | Choi et al[99], Wang et al[100] |
Visceral adiposity index | VAI | WC/(39.68 + 1.88 × BMI) × (TG/1.03) × (1.31/HDL) | Amato et al[101], Liu et al[102] |
Visceral fat | VF | Measured by bioelectrical impedance/magnetic resonance imaging | Lee et al[103] |
Waist circumference | WC | Measuring tape | Pustjens et al[104] |
Waist-to-height ratio | WHtr | WC/height | Sheng et al[105] |
Waist to hip ratio | WHr | WC/hip circumference as measured by measuring tape | Song et al[106] |
Weight-adjusted-waist index | WWI | WC/weight | Park et al[107], Lian et al[108] |
Zhejiang university index | ZJU | BMI + fasting plasma glucose + TG + 3 × ALT/AST ratio (+ 2, if woman) | Wang et al[109], Ma et al[110] |
- Citation: Priego-Parra BA, Román-Calleja BM, Gallego-Duran R, Gracia-Sancho J, Velarde Ruiz-Velasco JA, Remes-Troche JM. Triglyceride-glucose-waist circumference index: A powerful tool for metabolic dysfunction-associated steatotic liver disease. World J Hepatol 2025; 17(7): 107668
- URL: https://www.wjgnet.com/1948-5182/full/v17/i7/107668.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i7.107668